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Clinical and pathologic features of cardiac hemochromato- 
sis diagnosed by endomyocardial biopsy in six men, aged 32 
to 75 years (mean 52), are described. Echocardiography 
demonstrated left ventricular enlargement and marked 
global systolic dysfunction in five. Cardiac catheterization 
demonstrated normal coronary arteries, increased left ven- 
tricular end-diastolic pressure and decreased left ventricu- 
lar systolic function in all five so studied. Stainable iron was 
present in all endomyocardial biopsy specimens from the 
five patients with decreased left ventricular systolic func- 
tion. Histologically, iron was detected only within the 
In systemic iron overload disorders, the association between 
histologically demonstrable myocardial iron and cardiac 
dysfunction has been described in autopsy studies (1) but 
only rarely in studies based on cardiac biopsy or surgical 
specimens from living patients (2-4). Thus, the role of 
endomyocardial biopsy in the evaluation and management of 
cardiac hemochromatosis has not been defined. The ante- 
mortem diagnosis of cardiac hemochromatosis usually has 
been presumptive, based on findings of heart failure associ- 
ated with clinical and laboratory evidence of iron overload 
with or without improved cardiac function after periodic 
phlebotomy or chelation therapy (5-10). In some patients, 
cardiac failure is the sole or predominant manifestation of 
iron overload (7,l l), and cardiac involvement is the leading 
cause of death in this disorder (12,13). With these consider- 
ations in mind, this study was undertaken to describe 
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sarcoplasm, and its extent varied inversely with ventricular 
function. 
Thus, cardiac hemochromatosis represents a storage 
rather than an infiltrative disease. These results indicate 
that stainable iron is consistently observed in endomyocar- 
dial biopsy specimens from patients with impaired left 
ventricular systolic function. Iron staining is recommended 
for endomyocardial biopsy specimens from patients with 
idiopathic cardiac dysfunction. 
(J Am Co11 Cardiol1989;13:116-20) 
clinicopathologic correlations in six patients with cardiac 
hemochromatosis documented by endomyocardial biopsy. 
Methods 
Study patients. Among 642 endomyocardial biopsy spec- 
imens interpreted at our institution by one of us (W.D.E.) 
between 1977 and 1986, six patients with cardiac hemochro- 
matosis were identified by the presence of stainable iron in 
the myocardium. These patients constituted the study group. 
All patients had undergone echocardiographic examination, 
and five of the six had been studied by cardiac catheteriza- 
tion including left ventriculography and coronary arteriogra- 
phy. Three patients also had undergone right heart catheter- 
ization. For each of the patients in the study group, the 
clinical history, endomyocardial biopsy tissue, chest radio- 
graphs, electrocardiograms, echocardiograms and cardiac 
catheterization data were reviewed. 
Endomyocardial biopsy. In all patients, three to five 
endomyocardial samples were obtained (right ventricular in 
five and left ventricular in one). Biopsy specimens were fixed 
in 10% neutral buffered formalin, processed routinely for 
light microscopy and stained with hematoxylin-eosin, sul- 
fated alcian blue, Masson’s trichrome, and Gomori’s iron 
stains. The location of stainable iron was recorded. and the 
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Table 1. Clinical Features of Six Patients With Cardiac Hemochromatosis 
Feature Patient I Patient 2 Patient 3 Patient 4 Patient 5 Patient 6 
Age (yrjigender 
Hemochromatosis 
Associated disease 
3YM 
Genetic 
Familial hemolytic 
anemia: alcohol 
abuse 
33/M 
Genetic 
Hereditary 
rpherocytosiq 
46’M 55/M 
Genetic Genetic 
None None 
Duration of symptoms (mo) 
Presenting symptom(s) 
Chest radiograph 
Electrocardiogram 
EchocardIogram 
WTh (mm) (8 to I?) 
EDD (mm) (40 to 541 
EF (5?:i) 
Cardiac catheterization 
Hemodynamics 
LVEDP (mm Hg) 
RVEDP (mm Hg) 
PCWP (mm Hg) 
Angiograph) 
Coronary arteries 
Ventriculogram 
EDVI 
ESVI 
EF (‘i) 
Survival 9ince biopsy (mo) 
Dyspnea 
Cardiomegaly 
T-Wave 
abnormality 
II 8 IO II IO 
60 6X 62 60 66 
I6 31 34 I5 20 
?Y 
19 
IX 
Normal 
Severe LV 
hypokinesia 
I30 
96 
15 
8 IX I 
Dyspnea Dyspnea Dyspnea 
Cardiomegaly 
Long QT 
I8 
- 
Normal Normal 
Severe LV Severe LV 
hypokinesia hypokineaia 
174 144 
I02 I N+ 
41 34 
1 (died) 8 
Cardiomegdly 
I” AVB. LAD. AS 
& inf Q waves 
31 
- 
- 
69/M 75/M 
Acquired Acquired 
Sideroblastic Sideroblastic 
anemia anemia 
Cardiomegaly 
AF. LAD 
II 
Dypsnea. 
arthralgias 
Cdrdiomegal! 
LAD 
18 I6 
Y 16 
I1 I4 
Normal 
Severe LV 
hypokinesia 
- 
- 
15 
6 
Normal 
Severe LV 
hypokine5ia 
x7 
64 
16 
8 
6 
Dyspnea 
Cardiomegdly 
AF 
II 
50 
61 
- 
_ 
39 
AF = atrial fibrillation: AS = anteroseptal: AVB = atrioventricular block; EDD = end-diastolic diameter: EDVI = end-diastolic volume index: EF = ejection 
fraction: ESVI = end-systolic volume index: inf = inferior: LAD = left axis deviation: LVEDP = left ventricular end-diastolic pressure: M = male: PCWP = 
pulmonary capillary wedge pressure; RVEP = right ventricular end-diastolic pressure: WTh = wall thickness (expressed a, mean wall thickness of ventricular 
septum and lefr ventricular posterior walls; values in parentheses denote the normal range). 
degrees of stainable iron and collagen formation were ex- 
pressed as a grade of tissue involvement (normal = O%, 
grade 1 = I to 25%, grade 2 = 26 to 50$X, grade 3 = 5 1 to 75% 
and grade 4 = >75%). These determinations were performed 
by one of us (W.D.E.) without knowledge of clinical infor- 
mation. 
Results 
General features (Table 1). All six patients were men: 
their ages ranged from 32 to 75 years (mean 52). Four had 
genetic hemochromatosis diagnosed by standard clinical and 
laboratory criteria (12) including liver biopsy in three. The 
two youngest patients also had concurrent familial anemia. 
Two other patients had hemochromatosis associated with 
sideroblastic anemia; each also had undergone liver biopsy. 
No patient had a history of transfusion. One patient (Case 5) 
had taken iron orally for 2 years. 
Symptoms and survival. Dyspnea was a presenting symp- 
tom in all six patients and was associated with physical signs 
of congestive heart failure in five. Five patients are alive; one 
died of ventricular fibrillation 3 months after diagnosis. Of 
the five surviving patients. the three with genetic hemochro- 
matosis continue to undergo periodic phlebotomy. Each of 
the five is also being treated with digitalis and diuretics. 
One patient (Case I) admitted to heavy ulcohol use; he 
was advised to abstain from alcohol, and subsequent echo- 
cardiographic examination demonstrated normalization of 
left ventricular systolic function before initiation of a phle- 
botomy regimen. 
Laboratory findings (Table 2). Indicators of iron over- 
load, including transferrin saturation and ferritin concentra- 
tion, were abnormal in all six patients. The serum iron 
concentration, however, was normal in four of the six. 
Liver biopsy, performed in jive patients, demonstrated 
severe hemosiderosis in all and cirrhosis in three. Quantita- 
tion of elemental iron by atomic absorption spectroscopy in 
hepatic biopsy tissue demonstrated heavy iron overload in 
four of these five. In one patient (Case 4) with suspected 
genetic hemochromatosis, liver biopsy was not performed 
because histologic demonstration of iron overload was ob- 
tained on endomyocardial biopsy. 
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Table 2. Laboratory Features of Six Patients with Cardiac Hemochromatosis 
Feature Patient 1 Patient 2 Patient 3 Patient 4 Patient 5 Patient 6 
Hemoglobin (gidl)/hematocrit (%) 
Serum iron (&dl) (75 to 175)* 
Total iron-binding capacity (&dl) (240 to 450) 
Percent saturation (18 to 50%) 
Serum ferritin (~~hter) (20 to 300) 
Hepatic histologic findings 
Hemosiderosis 
Cirrhosis 
Hepatic iron concentration 
(kg/g dry weight) (530 to 900) 
12.6137.0 15.8144.2 15.6144.4 15.4/- 8.8126.5 9.8128.6 
209 172 147 133 170 300 
216 185 171 - 198 300 
97 93 86 - 86 100 
1,300 2,500 2,840 3,898 2,220 522 
Severe 
No 
20,292 
Severe 
Yes 
21,233 
Severe 
Yes 
22,969 
- Severe 
- Yes 
- 12,025 
Severe 
No 
NA 
*Values in parentheses indicate normal range. 
Curdiomegaly was observed by chest radiography in five 
of the six patients. Electrocardiography demonstrated non- 
specific abnormalities in all six patients (Table 1). 
Two-dimensional echocardiography, performed in all pa- 
tients, demonstrated left ventricular dilation and severe 
systolic dysfunction in five. The sixth patient had a normal- 
sized left ventricle with an ejection fraction of 61%. Ventric- 
ular wall thickness was normal in all patients, and no patient 
had regional wall motion abnormalities. 
Cardiac catheterization was performed in five of the six 
patients, and all five had increased left ventricular end- 
diastolic pressure. Ventriculography revealed left ventricu- 
lar enlargement and severe hypokinesia, and coronary angi- 
ography demonstrated normal coronary arteries in all five 
patients. One patient (Case 5) with severe left ventricular 
hypokinesia and normal coronary arteries had equalization 
of increased left and right ventricular end-diastolic pres- 
sures. 
Endomyocardial biopsy (Table 3). Light microscopic ex- 
amination of endomyocardial biopsy tissue that was stained 
for iron revealed sarcoplasmic iron in all six patients (Fig. 1). 
Iron was not observed within other types of cells or in 
extracellular spaces. Although the severity of iron deposi- 
tion varied from minimal to severe among the six patients, it 
tended to be consistent within biopsy specimens from indi- 
vidual patients. Furthermore, the histologic severity was 
directly related to the degree of left ventricular dysfunction 
(Fig. 2). 
Although the data suggest that a correlation may exist 
between left ventricular function and grade of stainable iron 
in endomyocardial biopsy specimens, the small sample size 
precluded a demonstration of statistical significance (Spear- 
man’s rank correlation coefficient = -0.80; p = 0.08). In one 
patient (Case 6) with normal left ventricular systolic func- 
tion, myocardial iron deposition was observed in only one of 
four endomyocardial biopsy specimens. Variation in sever- 
ity of iron deposition by anatomic site in individual patients 
and among different patients has been described previously 
in autopsy hearts from patients with hemochromatosis (14). 
Fibrosis was present in endomyocardial biopsy speci- 
mens from all patients; it was minimal in five cases and mild 
in one (Table 3). Similar observations were reported in an 
autopsy study of cardiac hemochromatosis (14). 
Discussion 
Diagnosis of bemocbromatosis. Cardiac hemochromatosis 
should be considered in any patient with unexplained heart 
failure. Screening for systemic iron overload includes deter- 
mination of transferrin saturation and ferritin concentration 
in serum. The combined specificity and sensitivity of these 
two screening tests is approximately 95% for the detection of 
Table 3. Histopathologic Features of Endomyocardial Biopsy Tissue From Six Patients With 
Cardiac Hemochromatosis 
Patient I Patient 2 Patient 3 Patient 4 Patient 5 Patient 6 
Specimens with iron/total 515 414 515 313 51s 114 
specimens 
Myocellular 
Iron (grade)* 3 2 4 4 2 1 
Hypertrophy Mild Moderate Mild Moderate Moderate Mild 
Degeneration Moderate Minimal Severe Minimal Minimal Mild 
Interstitial fibrosis 2 1 1 1 1 1 
(grade)* 
*Normal = O%, grade I = 1 to 25%, grade 2 = 26 to 50%, grade 3 = 51 to 75%, grade 4 = >75%. 
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Figure 1. Variation in quantity of stainable iron deposition in en- 
domyocardial biopsy tissue in two cases. Iron accumulation is 
limited to myocytes and tends to be perinuclear. A. Mild (grade 2): 
B. severe (grade 4). (Gomori iron: original magnification x 100, 
reduced by 33’2.) 
iron overload in patients with genetic hemochromatosis (IS). 
In contrast, serum iron concentration is not as reliable ( 15). 
If screening test results are consistent with iron overload, 
Figure 2. Inverse relation between left ventricular ejection fraction 
(EF) and grade of deposition of stainable iron in six cases of 
hemochromatosis. This relation was not statistically significant 
(Spearman’s rank correlation coefficient = -0.80: p = 0.08). 
0 1 2 3 4 
Iron, grade 
histologic confirmation of hemochromatosis is necessary. 
Generally, this has been accomplished by liver biopsy. 
Endomyocardial biopsy, however, may be indicated in pa- 
tients whose primary clinical manifestations are cardiac in 
origin. Furthermore, in experienced hands. transvenous 
right ventricular endomyocardial biopsy may be safer than 
percutaneous liver biopsy (16-18). 
Cardiac involvement in hemochromatosis. The hemody- 
namic and morphologic abnormalities of cardiac hemochro- 
matosis have been described as either dilated (2.5) or restric- 
tive (3) [cardiomyopathy]. Of the five patients with systolic 
functional abnormalities in this report, each had a dilated left 
ventricle and increased left ventricular end-diastolic pres- 
sure. No patient had the classic findings of restriction. Early 
cardiac involvement by hemochromatosis. however, may be 
manifested by diastolic or restrictive dysfunction. 
In a previous echocardiographic study (19), the authors 
suggested that increased wall thickness may be a feature of 
secondary posttransfusional hemochromatosis. However, 
others (8,9.14,20) have reported normal wall thickness in 
patients with nontransfusional hemochromatosis and cardiac 
dysfunction. In this study. all patients had normal ventricu- 
lar wall thickness as assessed by echocardiography. Accord- 
ingly. increased ventricular wall thickness does not appear 
to be a feature of nontransfusional cardiac hemochromato- 
sis. 
Endomyocardial biopsy in hemochromatosis. The micro- 
scopic features of endomyocardial biopsy tissue from four 
adolescents with transfusion-related hemochromatosis have 
been described (4). However, only one patient had cardiac 
dysfunction as determined by cardiac catheterization. Fur- 
thermore. in only one patient was abnormal accumulation of 
myocardial iron demonstrated, and this patient had normal 
cardiac function. These observations led the investigators (4) 
to conclude that endomyocardial biopsy is an insensitive 
method for the determination of ecrrly myocardial iron dep- 
osition in tr.cr,2~:firsiorz-relatrd hemochromatosis associated 
with thalassemia major. 
In contrast. the histopathologic characteristics of biopsy 
tissue from patients with nontrunsfirsionul cardiac hemo- 
chromatosis have been described in only two living patients 
(2,3); moreover, in one of these patients, biopsy tissue was 
obtained at pericardiectomy because the patient was pre- 
sumed to have pericardial constriction. Observations from 
the current investigation of six patients suggest that histo- 
logically demonstrable myocardial iron is a consistent 
finding in endomyocardial biopsy tissue from patients with 
nontran.~:frrsionrl iron overload and associated cardiac dys- 
function. Although cardiac iron deposition in hemochroma- 
tosis tends to be greater in subepicardial than in subendo- 
cardial regions ( 1.13.14), this factor does not appear to be a 
problem in the detection of cardiac iron by endomyocardial 
biopsy. 
There HUS \wriation in thr gmde of stcrinuhle iron in 
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endomyocardial tissue from the six patients, and this varia- 
tion was inversely related to left ventricular function. In all 
six cases, iron was sarcoplasmic and nor interstitial, indicat- 
ing that cardiac iron overload should be regarded as a 
storage disease rather than an infiltrative process. These 
observations confirm previous findings in a pathologic study 
(14) of patients with hemochromatosis. 
Fibrosis was present in all endomyocardial biopsy spec- 
imens from all of the study patients. However, the grade of 
fibrosis was minimal in five and mild in one despite severely 
decreased left ventricular function in four of the six patients. 
This observation suggests that fibrosis is not the only mech- 
anism responsible for ventricular dysfunction in cardiac 
hemochromatosis. 
Treatment of cardiac hemochromatosis. Cardiac dysfunc- 
tion associated with iron overload may be reversed after iron 
removal by either chelation (10) or phlebotomy (3,5-9). 
Because cardiac hemochromatosis is a potentially reversible 
disorder that may mimic idiopathic dilated or restrictive 
cardiomyopathy, it is recommended that endomyocardial 
biopsy tissue from patients with unexplained heart failure be 
stained for iron. In two of our six cases, the diagnosis was 
made by endomyocardial biopsy before clinical suspicion of 
the disorder. 
In patients with established cardiac hemochromatosis, 
serial endomyocardial biopsies may be indicated to docu- 
ment depletion of myocardial iron (12). In this regard, it is of 
interest that in their case report Short et al. (2) demonstrated 
persistence of myocardial iron on serial endomyocardial 
biopsies despite hypoferremia and microcytic anemia. Only 
after 6 years of monthly phlebotomy was iron completely 
absent from myocardial biopsy tissue. Therefore, in patients 
in whom periodic phlebotomy is not associated with a return 
to normal left ventricular function, serial endomyocardial 
biopsy should be considered to ensure that therapy has 
produced depletion of myocardial iron. 
We express appreciation to Robert L. Frye, MD for suggestions and review of 
the manuscript. 
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